Follow-up of patients with thoracic malignancies.
The optimal approach to the post-treatment management of patients with thoracic malignancies is a controversial topic. This is primarily because of the lack of widely accepted practice guidelines. Several guidelines have been promulgated for the follow-up of thoracic malignancies, but none have been tested in randomized controlled trials. The problem is an especially interesting one because little is known about how outcomes vary when the follow-up strategy is altered.
Virgo
K S
KS
Department of Surgery, Saint Louis University Health Sciences Center, Saint Louis, Missouri 63110-0250, USA. virgoks@slu.edu
Johnson
F E
FE
Naunheim
K S
KS
D003266:Continuity of Patient Care / Q000191:economics; D003365:Costs and Cost Analysis; D004938:Esophageal Neoplasms / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000191:economics / Q000628:therapy*; D008479:Mediastinal Neoplasms / Q000628:therapy*; D006278:Medicare / Q000191:economics; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D013899:Thoracic Neoplasms / Q000628:therapy*; D014481:United States